Your browser doesn't support javascript.
loading
Targeted sequencing identifies novel variants in common and rare MODY genes.
de Santana, Lucas S; Caetano, Lilian A; Costa-Riquetto, Aline D; Franco, Pedro C; Dotto, Renata P; Reis, André F; Weinert, Letícia S; Silveiro, Sandra P; Vendramini, Marcio F; do Prado, Flaviene A; Abrahão, Giovanna C P; de Almeida, Ana Gregória F P; Tavares, Maria da G Rodrigues; Gonçalves, Wagner Rodrigo B; Santomauro Junior, Augusto C; Halpern, Bruno; Jorge, Alexander A L; Nery, Marcia; Teles, Milena G.
Afiliação
  • de Santana LS; Monogenic Diabetes Group, Genetic Endocrinology Unit and Laboratory of Molecular & Cellular Endocrinology/LIM25, School of Medicine, University of Sao Paulo (USP), Sao Paulo, SP, Brazil.
  • Caetano LA; Monogenic Diabetes Group, Genetic Endocrinology Unit and Laboratory of Molecular & Cellular Endocrinology/LIM25, School of Medicine, University of Sao Paulo (USP), Sao Paulo, SP, Brazil.
  • Costa-Riquetto AD; Diabetes Unit, Clinics Hospital, School of Medicine, University of Sao Paulo (USP), Sao Paulo, SP, Brazil.
  • Franco PC; Monogenic Diabetes Group, Genetic Endocrinology Unit and Laboratory of Molecular & Cellular Endocrinology/LIM25, School of Medicine, University of Sao Paulo (USP), Sao Paulo, SP, Brazil.
  • Dotto RP; Diabetes Unit, Clinics Hospital, School of Medicine, University of Sao Paulo (USP), Sao Paulo, SP, Brazil.
  • Reis AF; Monogenic Diabetes Group, Genetic Endocrinology Unit and Laboratory of Molecular & Cellular Endocrinology/LIM25, School of Medicine, University of Sao Paulo (USP), Sao Paulo, SP, Brazil.
  • Weinert LS; Diabetes Unit, Clinics Hospital, School of Medicine, University of Sao Paulo (USP), Sao Paulo, SP, Brazil.
  • Silveiro SP; Departamento de Medicina, Disciplina de Endocrinologia, Universidade Federal de São Paulo (UNIFESP), Sao Paulo, SP, Brazil.
  • Vendramini MF; Departamento de Medicina, Disciplina de Endocrinologia, Universidade Federal de São Paulo (UNIFESP), Sao Paulo, SP, Brazil.
  • do Prado FA; Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, RS, Brazil.
  • Abrahão GCP; Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, RS, Brazil.
  • de Almeida AGFP; Serviço de Endocrinologia, Hospital do Servidor Público Estadual de São Paulo (HSPE-SP), Sao Paulo, SP, Brazil.
  • Tavares MDGR; Hospital Regional de Taguatinga da Secretaria de Saúde do Distrito Federal, Taguatinga, DF, Brazil.
  • Gonçalves WRB; Pontifícia Universidade Católica de São Paulo (PUCSP), Sao Paulo, SP, Brazil.
  • Santomauro Junior AC; Instituto Federal de Educação, Ciência e Tecnologia do Maranhão (IFMA), Sao Luis, MA, Brazil.
  • Halpern B; Serviço de Endocrinologia do Hospital Universitário, Universidade Federal do Maranhão (UFMA), Sao Luis, MA, Brazil.
  • Jorge AAL; Hospital do Servidor Público Municipal de São Paulo (HSPM-SP), Sao Paulo, SP, Brazil.
  • Nery M; Serviço de Endocrinologia Prof. Dr. Fadlo Fraige Filho, Hospital Beneficência Portuguesa de São Paulo (BP-SP), Sao Paulo, SP, Brazil.
  • Teles MG; Departamento de Endocrinologia e Metabologia, Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo (USP), Sao Paulo, SP, Brazil.
Mol Genet Genomic Med ; 7(12): e962, 2019 12.
Article em En | MEDLINE | ID: mdl-31595705
BACKGROUND: Maturity-onset diabetes of the young (MODY) is a form of monogenic diabetes with autosomal dominant inheritance. To date, mutations in 11 genes have been frequently associated with this phenotype. In Brazil, few cohorts have been screened for MODY, all using a candidate gene approach, with a high prevalence of undiagnosed cases (MODY-X). METHODS: We conducted a next-generation sequencing target panel (tNGS) study to investigate, for the first time, a Brazilian cohort of MODY patients with a negative prior genetic analysis. One hundred and two patients were selected, of which 26 had an initial clinical suspicion of MODY-GCK and 76 were non-GCK MODY. RESULTS: After excluding all benign and likely benign variants and variants of uncertain significance, we were able to assign a genetic cause for 12.7% (13/102) of the probands. Three rare MODY subtypes were identified (PDX1/NEUROD1/ABCC8), and eight variants had not been previously described/mapped in genomic databases. Important clinical findings were evidenced in some cases after genetic diagnosis, such as MODY-PDX1/HNF1B. CONCLUSION: A multiloci genetic approach allowed the identification of rare MODY subtypes, reducing the large percentage of MODY-X in Brazilian cases and contributing to a better clinical, therapeutic, and prognostic characterization of these rare phenotypes.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Testes Genéticos / Diabetes Mellitus Tipo 2 / Sequenciamento de Nucleotídeos em Larga Escala Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Female / Humans / Male País/Região como assunto: America do sul / Brasil Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Testes Genéticos / Diabetes Mellitus Tipo 2 / Sequenciamento de Nucleotídeos em Larga Escala Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Female / Humans / Male País/Região como assunto: America do sul / Brasil Idioma: En Ano de publicação: 2019 Tipo de documento: Article